EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration

Yurina Shishido, Tomohiro Yoshida, Keiyu Oshida, Masashi Uchida iD

Pharmacology Research & Perspectives · 2024

DOI: 10.1002/prp2.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Yurina Shishido und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research Laboratories, Toray Industries, Inc., Kamakura, Kanagawa, Japan. Hauptthemen laut MEDLINE: Rifampin, Hepatocytes, Mice, Inbred ICR, Coproporphyrins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interest in transporter‐mediated drug interactions has been increasing in the field of drug development. In this study, we measured the plasma and urinary concentrations of coproporphyrin (CP) I and CP III as endogenous substrates for organic anion‐transporting polypeptide (OATP) using chimeric mice with human hepatocytes (PXB mice) and examined the influence of an OATP inhibitor, rifampicin (RIF). CP I and CP III were actively taken up intracellularly, and RIF inhibited the uptake in a concentration‐dependent manner for both CP I and CP III in human hepatocytes (PXB‐cells). Single doses of RIF at 10 and 30 mg/kg were orally or intravenously administered to PXB mice and wild‐type ICR mice. Plasma concentrations (AUC 0‐8h ) of CP I increased in both mice. However, a marked increase in CP III was only observed in ICR mice, after intravenous administration of RIF at 30 mg/kg. The IC 50 values of RIF for intracellular CP I/III uptake and the unbound plasma concentrations of RIF suggested that the increase in plasma CP I is associated with the exposure of RIF to OATPs. The 24‐h cumulative urinary excretions of CP I and CP III increased in both mice, but more markedly in PXB mice. Thus, RIF increased the plasma and urinary concentrations of CP I and CP III in the mice, as reported in humans, and CP I may be a more sensitive biomarker of OATP‐mediated drug interactions in PXB mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinHepatocytesMice, Inbred ICRCoproporphyrinsAnimalsHumansMiceMaleOrganic Anion TransportersDrug InteractionsChimeraAdministration, Intravenous

Stichwörter der Autor:innen

PXB micecoproporphyrinsorganic anion‐transporting polypeptide (OATP)rifampicintransporter‐mediated drug interactions

Substanzen

RifampinCoproporphyrinscoproporphyrin IOrganic Anion Transporters

Autor:innen und Institutionen

  • Pharmaceutical Research Laboratories, Toray Industries, Inc., Kamakura, Kanagawa, Japan.

ORCID-Profile: Masashi Uchida

Zitieren

APA

Shishido, Y., Yoshida, T., Oshida, K., & Uchida, M. (2024). Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70017

Vancouver

Shishido Y, Yoshida T, Oshida K, Uchida M. Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.70017

BibTeX
@article{Shishido2024,
  author = {Shishido, Yurina and Yoshida, Tomohiro and Oshida, Keiyu and Uchida, Masashi},
  title = {Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  doi = {10.1002/prp2.70017}
}
Kostenlos starten →